{"transactions":[{"id":4621190,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-09-17T20:15:13.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":2650,"price":22,"value":58300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025."}],"balance_after":177390,"source":{"system":"sec-edgar","filing":"0002048500-26-000013","document":"form4-09172026_040904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048500/000204850026000013/form4-09172026_040904.xml","form_type":"4"}},{"id":3381,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-09-03T22:15:11.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":4375,"price":19.1131,"value":83619.8125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":180040,"source":{"system":"sec-edgar","filing":"0002048500-26-000012","document":"form4-09032026_060904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048500/000204850026000012/form4-09032026_060904.xml","form_type":"4"}},{"id":751753,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-06-03T22:13:50.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":4378,"price":12.6071,"value":55193.8838,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":184415,"source":{"system":"sec-edgar","filing":"0002048500-26-000009","document":"form4-06032026_100646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000009/form4-06032026_100646.xml","form_type":"4"}},{"id":843898,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-13T20:15:23.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":91520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":91520,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":91520},"source":{"system":"sec-edgar","filing":"0002048500-26-000006","document":"form4a-03132026_040314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000006/form4a-03132026_040314.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":867179,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T23:45:11.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":58749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":58749,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":58749},"source":{"system":"sec-edgar","filing":"0002048500-26-000004","document":"form4-03032026_060306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000004/form4-03032026_060306.xml","form_type":"4"}},{"id":867178,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:11.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1064,"price":12.3616,"value":13152.7424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":188793,"source":{"system":"sec-edgar","filing":"0002048500-26-000004","document":"form4-03032026_060306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000004/form4-03032026_060306.xml","form_type":"4"}},{"id":867177,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:11.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":109105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":189857,"source":{"system":"sec-edgar","filing":"0002048500-26-000004","document":"form4-03032026_060306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000004/form4-03032026_060306.xml","form_type":"4"}},{"id":944517,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-01-07T21:16:36.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":2200,"price":30.1005,"value":66221.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $30.1005 and the range of prices were between $30.00 and $30.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":80752,"source":{"system":"sec-edgar","filing":"0002048500-26-000003","document":"form4-01072026_090132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000003/form4-01072026_090132.xml","form_type":"4"}},{"id":951511,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-01-05T23:05:25.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":600,"price":30.1969,"value":18118.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $30.1969 and the range of prices were between $30.10 and $30.52. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":82952,"source":{"system":"sec-edgar","filing":"0002048500-26-000002","document":"form4-01052026_110121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000002/form4-01052026_110121.xml","form_type":"4"}},{"id":951510,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-01-05T23:05:25.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":7200,"price":29.56,"value":212832.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $29.56 and the range of prices were between $29.05 and $30.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":83552,"source":{"system":"sec-edgar","filing":"0002048500-26-000002","document":"form4-01052026_110121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000002/form4-01052026_110121.xml","form_type":"4"}},{"id":980312,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:20:10.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":1063,"price":29.3359,"value":31184.0617,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":90752,"source":{"system":"sec-edgar","filing":"0002048500-25-000004","document":"form4-12042025_041205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850025000004/form4-12042025_041205.xml","form_type":"4"}},{"id":1047920,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-09-04T22:45:09.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":1089,"price":18.8632,"value":20542.0248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":91815,"source":{"system":"sec-edgar","filing":"0001415889-25-023744","document":"form4-09042025_060906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023744/form4-09042025_060906.xml","form_type":"4"}},{"id":1122936,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:15.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":101,"price":18.691,"value":1887.791,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":92904,"source":{"system":"sec-edgar","filing":"0001415889-25-015668","document":"form4-06042025_070612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015668/form4-06042025_070612.xml","form_type":"4"}},{"id":1122935,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:15.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":708,"price":18.1489,"value":12849.4212,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":93005,"source":{"system":"sec-edgar","filing":"0001415889-25-015668","document":"form4-06042025_070612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015668/form4-06042025_070612.xml","form_type":"4"}},{"id":1122934,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:15.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":306,"price":17.028,"value":5210.568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":93713,"source":{"system":"sec-edgar","filing":"0001415889-25-015668","document":"form4-06042025_070612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015668/form4-06042025_070612.xml","form_type":"4"}},{"id":1235829,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-03T22:45:10.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025."}],"balance_after":52000,"derivative":{"exercise_price":19.91,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001415889-25-006232","document":"form4-03032025_050306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925006232/form4-03032025_050306.xml","form_type":"4"}},{"id":1235828,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-03-03T22:45:10.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":94019,"source":{"system":"sec-edgar","filing":"0001415889-25-006232","document":"form4-03032025_050306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925006232/form4-03032025_050306.xml","form_type":"4"}},{"id":1287408,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:15.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":110278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F6","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":110278,"derivative":{"exercise_price":17,"expiration_date":"2025-01-28","underlying":"Common Stock","underlying_shares":110278},"source":{"system":"sec-edgar","filing":"0001415889-25-002819","document":"form4-02032025_080211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002819/form4-02032025_080211.xml","form_type":"4"}},{"id":1287407,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:15.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":236553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-fourth of the shares subject to this option shall vest one year after August 1, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F6","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":236553,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":236553},"source":{"system":"sec-edgar","filing":"0001415889-25-002819","document":"form4-02032025_080211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002819/form4-02032025_080211.xml","form_type":"4"}},{"id":1287406,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Class B Common Stock Warrant (right to buy)","published_at":"2025-02-04T01:30:15.000Z","date":"2025-01-31","kind":"other","planned":false,"acquired":false,"shares":10575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this warrant was converted into an equal number of shares of Common Stock."}],"balance_after":0,"derivative":{"exercise_price":0.02,"exercise_date":"2023-08-28","expiration_date":"2033-08-27","underlying":"Common Stock","underlying_shares":10575},"source":{"system":"sec-edgar","filing":"0001415889-25-002819","document":"form4-02032025_080211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002819/form4-02032025_080211.xml","form_type":"4"}},{"id":1287405,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Class B Common Stock Warrant (right to buy)","published_at":"2025-02-04T01:30:15.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":10575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this warrant was converted into an equal number of shares of Common Stock."}],"balance_after":10575,"derivative":{"exercise_price":0.02,"exercise_date":"2023-08-28","expiration_date":"2033-08-27","underlying":"Common Stock","underlying_shares":10575},"source":{"system":"sec-edgar","filing":"0001415889-25-002819","document":"form4-02032025_080211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002819/form4-02032025_080211.xml","form_type":"4"}},{"id":1287404,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Series D Preferred Stock","published_at":"2025-02-04T01:30:15.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":15107,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the \"Preferred Stock\") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the \"Preferred Stock\") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the \"Preferred Stock\") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the \"Preferred Stock\") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the \"Preferred Stock\") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15107},"source":{"system":"sec-edgar","filing":"0001415889-25-002819","document":"form4-02032025_080211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002819/form4-02032025_080211.xml","form_type":"4"}},{"id":1287403,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-02-04T01:30:15.000Z","date":"2025-01-31","kind":"purchase","planned":false,"acquired":true,"shares":33350,"price":17,"value":566950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were purchased in the Issuer's initial public offering."}],"balance_after":59019,"source":{"system":"sec-edgar","filing":"0001415889-25-002819","document":"form4-02032025_080211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002819/form4-02032025_080211.xml","form_type":"4"}},{"id":1287402,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-02-04T01:30:15.000Z","date":"2025-01-31","kind":"sale","planned":false,"acquired":false,"shares":13,"price":17,"value":221.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 31, 2025, the reporting person exercised a warrant to purchase 10,575 shares of Issuer's common stock for $0.02 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in withholding of 13 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 10,562 shares."}],"balance_after":25669,"source":{"system":"sec-edgar","filing":"0001415889-25-002819","document":"form4-02032025_080211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002819/form4-02032025_080211.xml","form_type":"4"}},{"id":1287401,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-02-04T01:30:15.000Z","date":"2025-01-31","kind":"other","planned":false,"acquired":true,"shares":10575,"price":0.02,"value":211.5,"ownership":{"direct":true},"balance_after":25682,"source":{"system":"sec-edgar","filing":"0001415889-25-002819","document":"form4-02032025_080211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002819/form4-02032025_080211.xml","form_type":"4"}},{"id":1287400,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-02-04T01:30:15.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":15107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the \"Preferred Stock\") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date."}],"balance_after":15107,"source":{"system":"sec-edgar","filing":"0001415889-25-002819","document":"form4-02032025_080211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002819/form4-02032025_080211.xml","form_type":"4"}},{"id":1289523,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-31T21:32:46.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":110278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":110278,"derivative":{"exercise_price":17,"expiration_date":"2035-01-28","underlying":"Class B Common Stock","underlying_shares":110278},"source":{"system":"sec-edgar","filing":"0001415889-25-002481","document":"form4-01312025_090141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002481/form4-01312025_090141.xml","form_type":"4"}}]}